 Csaba Galambos
Concepts (473)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Alveoli | 15 | 2023 | 373 | 2.940 |
Why?
| | Persistent Fetal Circulation Syndrome | 9 | 2023 | 132 | 2.660 |
Why?
| | Lung | 29 | 2023 | 3561 | 2.620 |
Why?
| | Pulmonary Artery | 11 | 2021 | 1016 | 2.450 |
Why?
| | Respiratory Insufficiency | 5 | 2023 | 290 | 2.290 |
Why?
| | Pulmonary Veins | 5 | 2019 | 81 | 1.840 |
Why?
| | Arteriovenous Anastomosis | 4 | 2022 | 13 | 1.720 |
Why?
| | Bronchial Arteries | 3 | 2018 | 11 | 1.710 |
Why?
| | Bronchi | 6 | 2023 | 232 | 1.550 |
Why?
| | Down Syndrome | 6 | 2021 | 335 | 1.310 |
Why?
| | Hypertension, Pulmonary | 14 | 2022 | 1729 | 1.310 |
Why?
| | Pulmonary Circulation | 7 | 2022 | 407 | 1.290 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 20 | 1.200 |
Why?
| | Infant, Newborn | 34 | 2023 | 5047 | 1.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2023 | 190 | 1.070 |
Why?
| | T-Box Domain Proteins | 3 | 2023 | 92 | 1.050 |
Why?
| | Immunohistochemistry | 13 | 2017 | 1629 | 1.050 |
Why?
| | Infant | 36 | 2023 | 7964 | 1.040 |
Why?
| | Homeodomain Proteins | 4 | 2017 | 463 | 1.040 |
Why?
| | Lung Diseases, Interstitial | 6 | 2021 | 508 | 1.020 |
Why?
| | Abnormalities, Multiple | 3 | 2016 | 178 | 0.950 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 329 | 0.940 |
Why?
| | Heart Defects, Congenital | 6 | 2022 | 671 | 0.920 |
Why?
| | Lung Diseases | 7 | 2021 | 701 | 0.870 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 3 | 2014 | 57 | 0.860 |
Why?
| | Lymphatic Vessels | 3 | 2009 | 54 | 0.850 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 130 | 0.830 |
Why?
| | Sudden Infant Death | 1 | 2022 | 24 | 0.810 |
Why?
| | Cardiovascular Abnormalities | 1 | 2022 | 10 | 0.810 |
Why?
| | Capillaries | 3 | 2014 | 91 | 0.770 |
Why?
| | Humans | 87 | 2023 | 114696 | 0.740 |
Why?
| | Graft Rejection | 5 | 2013 | 513 | 0.680 |
Why?
| | Mutation | 12 | 2023 | 3346 | 0.680 |
Why?
| | Child, Preschool | 25 | 2021 | 9118 | 0.680 |
Why?
| | Tumor Suppressor Proteins | 3 | 2011 | 282 | 0.670 |
Why?
| | Histological Techniques | 2 | 2009 | 40 | 0.640 |
Why?
| | Death, Sudden | 1 | 2019 | 27 | 0.640 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 135 | 0.640 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 82 | 0.620 |
Why?
| | Child | 36 | 2023 | 18420 | 0.610 |
Why?
| | Pneumonia | 2 | 2022 | 568 | 0.610 |
Why?
| | Fatal Outcome | 7 | 2019 | 284 | 0.610 |
Why?
| | Gene Deletion | 1 | 2019 | 356 | 0.590 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.580 |
Why?
| | Imaging, Three-Dimensional | 4 | 2019 | 512 | 0.570 |
Why?
| | Virus Diseases | 2 | 2009 | 195 | 0.550 |
Why?
| | Airway Obstruction | 1 | 2019 | 168 | 0.540 |
Why?
| | Collagen Type VIII | 1 | 2016 | 2 | 0.540 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2016 | 7 | 0.540 |
Why?
| | Collagen Type IV | 1 | 2016 | 22 | 0.540 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2016 | 54 | 0.530 |
Why?
| | Male | 48 | 2023 | 55604 | 0.530 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2015 | 11 | 0.510 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 215 | 0.510 |
Why?
| | Veins | 1 | 2016 | 55 | 0.510 |
Why?
| | Microvessels | 1 | 2016 | 68 | 0.500 |
Why?
| | Sarcoma | 1 | 2017 | 137 | 0.500 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 179 | 0.490 |
Why?
| | Female | 43 | 2022 | 59518 | 0.470 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2014 | 186 | 0.470 |
Why?
| | Hypoxia | 2 | 2019 | 958 | 0.470 |
Why?
| | Arteriovenous Fistula | 1 | 2014 | 29 | 0.460 |
Why?
| | Transcription Factors | 3 | 2023 | 1528 | 0.450 |
Why?
| | Nuclear Proteins | 2 | 2010 | 591 | 0.440 |
Why?
| | Autoantigens | 1 | 2016 | 396 | 0.440 |
Why?
| | Tomography, X-Ray Computed | 8 | 2022 | 2286 | 0.430 |
Why?
| | Lymphangiogenesis | 2 | 2011 | 24 | 0.420 |
Why?
| | Antibodies, Monoclonal | 3 | 2009 | 1262 | 0.410 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 6 | 0.410 |
Why?
| | ABO Blood-Group System | 2 | 2011 | 32 | 0.410 |
Why?
| | Endothelium, Lymphatic | 3 | 2009 | 12 | 0.410 |
Why?
| | Complement C4b | 2 | 2013 | 9 | 0.400 |
Why?
| | Sensitivity and Specificity | 6 | 2017 | 1693 | 0.390 |
Why?
| | Diagnosis, Differential | 8 | 2017 | 1342 | 0.380 |
Why?
| | Heart Neoplasms | 2 | 2022 | 49 | 0.370 |
Why?
| | Biomarkers | 7 | 2020 | 3408 | 0.370 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1040 | 0.360 |
Why?
| | Phosphoproteins | 2 | 2018 | 298 | 0.360 |
Why?
| | Erythema | 1 | 2010 | 25 | 0.350 |
Why?
| | Vena Cava, Superior | 1 | 2010 | 21 | 0.350 |
Why?
| | Forkhead Transcription Factors | 3 | 2023 | 170 | 0.350 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2010 | 35 | 0.340 |
Why?
| | Vena Cava, Inferior | 1 | 2010 | 56 | 0.340 |
Why?
| | Scalp | 2 | 2010 | 29 | 0.340 |
Why?
| | Asthma | 2 | 2021 | 2029 | 0.330 |
Why?
| | Ranula | 1 | 2009 | 3 | 0.330 |
Why?
| | Mucocele | 1 | 2009 | 11 | 0.330 |
Why?
| | Pleural Effusion | 2 | 2021 | 47 | 0.320 |
Why?
| | Hemodynamics | 5 | 2021 | 1012 | 0.320 |
Why?
| | Pathology | 1 | 2009 | 20 | 0.320 |
Why?
| | Blood Group Antigens | 1 | 2009 | 14 | 0.320 |
Why?
| | Vascular Malformations | 1 | 2009 | 47 | 0.310 |
Why?
| | Adolescent | 16 | 2020 | 17853 | 0.310 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2021 | 42 | 0.300 |
Why?
| | Phenotype | 5 | 2023 | 2796 | 0.300 |
Why?
| | Cryopreservation | 1 | 2009 | 92 | 0.300 |
Why?
| | Peptide Fragments | 2 | 2013 | 666 | 0.290 |
Why?
| | Viruses | 1 | 2009 | 94 | 0.290 |
Why?
| | Endocardium | 1 | 2007 | 30 | 0.290 |
Why?
| | Heart Transplantation | 3 | 2013 | 665 | 0.290 |
Why?
| | Hemorrhage | 2 | 2021 | 620 | 0.280 |
Why?
| | Young Adult | 7 | 2023 | 10471 | 0.280 |
Why?
| | Infant, Premature | 3 | 2023 | 476 | 0.280 |
Why?
| | Heart Ventricles | 4 | 2022 | 712 | 0.260 |
Why?
| | Vascular Resistance | 2 | 2019 | 337 | 0.260 |
Why?
| | Temporal Muscle | 1 | 2005 | 2 | 0.260 |
Why?
| | Herpesvirus 8, Human | 1 | 2006 | 61 | 0.250 |
Why?
| | Choristoma | 1 | 2005 | 23 | 0.250 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3535 | 0.250 |
Why?
| | Thyroid Nuclear Factor 1 | 2 | 2019 | 14 | 0.250 |
Why?
| | Neovascularization, Physiologic | 1 | 2007 | 173 | 0.250 |
Why?
| | Lymphatic Vessel Tumors | 1 | 2005 | 1 | 0.250 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 351 | 0.240 |
Why?
| | Synchrotrons | 2 | 2021 | 8 | 0.230 |
Why?
| | Microscopy, Phase-Contrast | 2 | 2021 | 18 | 0.230 |
Why?
| | Soft Tissue Neoplasms | 1 | 2005 | 90 | 0.230 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 73 | 0.230 |
Why?
| | Lung Transplantation | 2 | 2019 | 246 | 0.220 |
Why?
| | Hemangiopericytoma | 1 | 2003 | 3 | 0.210 |
Why?
| | Biopsy | 8 | 2022 | 1036 | 0.210 |
Why?
| | Severity of Illness Index | 5 | 2018 | 2540 | 0.210 |
Why?
| | Aorta | 2 | 2019 | 386 | 0.210 |
Why?
| | Infant Death | 1 | 2022 | 4 | 0.210 |
Why?
| | Arteriovenous Malformations | 1 | 2022 | 24 | 0.210 |
Why?
| | Antibodies, Viral | 1 | 2006 | 520 | 0.200 |
Why?
| | Fibrin | 1 | 2023 | 65 | 0.200 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 50 | 0.200 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.200 |
Why?
| | Lymphokines | 1 | 2002 | 111 | 0.200 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 48 | 0.200 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 38 | 0.200 |
Why?
| | Myocardium | 2 | 2017 | 913 | 0.200 |
Why?
| | Cell Proliferation | 4 | 2019 | 2187 | 0.200 |
Why?
| | Epilepsy | 1 | 2005 | 278 | 0.190 |
Why?
| | Vascular Remodeling | 2 | 2021 | 153 | 0.190 |
Why?
| | Sjogren's Syndrome | 1 | 2021 | 41 | 0.190 |
Why?
| | Protein C | 1 | 2021 | 45 | 0.180 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 18 | 0.180 |
Why?
| | Adult | 9 | 2023 | 30552 | 0.180 |
Why?
| | Vasculitis | 1 | 2021 | 66 | 0.180 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 92 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2021 | 12554 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2021 | 137 | 0.170 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 188 | 0.170 |
Why?
| | Pulmonary Heart Disease | 1 | 2019 | 6 | 0.160 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2019 | 19 | 0.160 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| | Mitochondrial Diseases | 1 | 2020 | 77 | 0.160 |
Why?
| | Heterozygote | 1 | 2019 | 251 | 0.160 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2018 | 13 | 0.160 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 25 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2019 | 154 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 207 | 0.150 |
Why?
| | Silicosis | 1 | 2018 | 21 | 0.150 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 24 | 0.150 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2018 | 21 | 0.150 |
Why?
| | Catheterization, Swan-Ganz | 1 | 2018 | 8 | 0.150 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.150 |
Why?
| | Mice, Knockout | 1 | 2004 | 2570 | 0.150 |
Why?
| | Gene Expression | 1 | 2023 | 1421 | 0.150 |
Why?
| | Heart Failure | 3 | 2021 | 1945 | 0.150 |
Why?
| | Nervous System Malformations | 1 | 2018 | 34 | 0.150 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 101 | 0.150 |
Why?
| | Macrophages, Alveolar | 2 | 2012 | 348 | 0.150 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 86 | 0.150 |
Why?
| | Histiocytosis | 1 | 2017 | 8 | 0.150 |
Why?
| | Multiple Myeloma | 1 | 2019 | 93 | 0.150 |
Why?
| | Contracture | 1 | 2017 | 23 | 0.140 |
Why?
| | Early Medical Intervention | 1 | 2018 | 52 | 0.140 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 12 | 0.140 |
Why?
| | Pleurisy | 1 | 2017 | 6 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2023 | 1019 | 0.140 |
Why?
| | Up-Regulation | 2 | 2020 | 808 | 0.140 |
Why?
| | Uremia | 1 | 2017 | 14 | 0.140 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.140 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 6 | 0.140 |
Why?
| | Kidney | 2 | 2022 | 1188 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2020 | 237 | 0.140 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 349 | 0.140 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 42 | 0.140 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2017 | 60 | 0.140 |
Why?
| | Collagen Type XVIII | 1 | 2016 | 4 | 0.140 |
Why?
| | Syndrome | 2 | 2010 | 333 | 0.140 |
Why?
| | Myocardial Contraction | 1 | 2018 | 313 | 0.130 |
Why?
| | Sacrum | 1 | 2017 | 65 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 520 | 0.130 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 380 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2003 | 731 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 250 | 0.130 |
Why?
| | Cadaver | 2 | 2015 | 299 | 0.130 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.130 |
Why?
| | Autopsy | 1 | 2016 | 84 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2021 | 3003 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2020 | 695 | 0.130 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 89 | 0.130 |
Why?
| | Cell Transdifferentiation | 1 | 2015 | 31 | 0.130 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2015 | 52 | 0.130 |
Why?
| | Marijuana Smoking | 1 | 2018 | 224 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 594 | 0.120 |
Why?
| | Pancreatic Ducts | 1 | 2015 | 69 | 0.120 |
Why?
| | Pregnancy | 4 | 2019 | 5520 | 0.120 |
Why?
| | Algorithms | 1 | 2022 | 1469 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 194 | 0.120 |
Why?
| | Muscle Proteins | 1 | 2016 | 210 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 870 | 0.120 |
Why?
| | Adventitia | 1 | 2014 | 37 | 0.120 |
Why?
| | Alanine Transaminase | 2 | 2013 | 142 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 740 | 0.110 |
Why?
| | Brain | 1 | 2005 | 2371 | 0.110 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2013 | 11 | 0.110 |
Why?
| | Animals | 12 | 2023 | 31708 | 0.110 |
Why?
| | Macaca fascicularis | 1 | 2013 | 50 | 0.110 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 25 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2016 | 388 | 0.110 |
Why?
| | I-kappa B Proteins | 1 | 2014 | 79 | 0.110 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 348 | 0.110 |
Why?
| | Adenofibroma | 1 | 2013 | 2 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1518 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1355 | 0.110 |
Why?
| | Mucin-5B | 1 | 2015 | 183 | 0.110 |
Why?
| | Infant, Extremely Premature | 1 | 2013 | 57 | 0.100 |
Why?
| | Hyperoxia | 1 | 2014 | 99 | 0.100 |
Why?
| | Hepatocytes | 1 | 2013 | 195 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 590 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 129 | 0.100 |
Why?
| | Osteopetrosis | 1 | 2012 | 1 | 0.100 |
Why?
| | Mandibular Neoplasms | 1 | 2012 | 22 | 0.100 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2012 | 12 | 0.100 |
Why?
| | Nephrectomy | 1 | 2013 | 150 | 0.100 |
Why?
| | Prognosis | 4 | 2021 | 3329 | 0.100 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 24 | 0.100 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 317 | 0.100 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 52 | 0.100 |
Why?
| | Blood Group Incompatibility | 1 | 2011 | 14 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1737 | 0.090 |
Why?
| | Glycogen Storage Disease Type III | 1 | 2011 | 1 | 0.090 |
Why?
| | Lung Injury | 1 | 2014 | 198 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 801 | 0.090 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 377 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 66 | 0.090 |
Why?
| | Transplants | 1 | 2011 | 36 | 0.090 |
Why?
| | Sympathetic Nervous System | 1 | 2011 | 171 | 0.090 |
Why?
| | Mannose-Binding Lectins | 1 | 2010 | 13 | 0.090 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2010 | 9 | 0.090 |
Why?
| | MicroRNAs | 1 | 2016 | 600 | 0.090 |
Why?
| | Lectins, C-Type | 1 | 2010 | 61 | 0.090 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2010 | 2 | 0.090 |
Why?
| | Antigens, CD1 | 1 | 2010 | 57 | 0.090 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 24 | 0.090 |
Why?
| | NF-kappa B | 1 | 2014 | 641 | 0.090 |
Why?
| | Thyroid Diseases | 1 | 2010 | 30 | 0.090 |
Why?
| | Multiple Organ Failure | 2 | 2012 | 146 | 0.080 |
Why?
| | Vascular Stiffness | 1 | 2014 | 407 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 743 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 2015 | 726 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1314 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 84 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 6116 | 0.080 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 49 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2011 | 323 | 0.080 |
Why?
| | Tissue Preservation | 1 | 2009 | 12 | 0.080 |
Why?
| | Disease Management | 1 | 2013 | 560 | 0.080 |
Why?
| | Antigens, CD34 | 1 | 2009 | 89 | 0.080 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 327 | 0.080 |
Why?
| | Hip Joint | 1 | 2010 | 126 | 0.080 |
Why?
| | Ki-67 Antigen | 1 | 2009 | 103 | 0.080 |
Why?
| | Sampling Studies | 1 | 2009 | 93 | 0.080 |
Why?
| | Face | 1 | 2010 | 164 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 125 | 0.080 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 116 | 0.080 |
Why?
| | Acute Disease | 1 | 2011 | 911 | 0.080 |
Why?
| | Middle Aged | 5 | 2016 | 26737 | 0.080 |
Why?
| | Papillomaviridae | 1 | 2009 | 101 | 0.080 |
Why?
| | Adenoviridae | 1 | 2009 | 184 | 0.080 |
Why?
| | Blood-Air Barrier | 1 | 2008 | 10 | 0.080 |
Why?
| | Cytomegalovirus | 1 | 2009 | 144 | 0.070 |
Why?
| | Antigens, CD | 1 | 2010 | 442 | 0.070 |
Why?
| | Paraffin Embedding | 1 | 2007 | 21 | 0.070 |
Why?
| | Pulmonary Valve | 1 | 2009 | 89 | 0.070 |
Why?
| | Hormones | 1 | 2008 | 132 | 0.070 |
Why?
| | Wound Healing | 1 | 2009 | 258 | 0.070 |
Why?
| | Lower Extremity | 1 | 2010 | 335 | 0.070 |
Why?
| | Graft Survival | 1 | 2009 | 446 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2765 | 0.070 |
Why?
| | Fetal Death | 1 | 2006 | 50 | 0.070 |
Why?
| | Liver | 1 | 2013 | 1637 | 0.060 |
Why?
| | Insulin | 1 | 2015 | 2080 | 0.060 |
Why?
| | Sequence Deletion | 2 | 2022 | 167 | 0.060 |
Why?
| | Fetal Development | 1 | 2008 | 248 | 0.060 |
Why?
| | Specimen Handling | 1 | 2006 | 155 | 0.060 |
Why?
| | Rhabdomyosarcoma | 1 | 2005 | 54 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2021 | 663 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2363 | 0.060 |
Why?
| | Fibrosis | 2 | 2017 | 453 | 0.060 |
Why?
| | Neuroglia | 1 | 2005 | 150 | 0.060 |
Why?
| | Sheep | 2 | 2019 | 764 | 0.060 |
Why?
| | Comorbidity | 2 | 2020 | 1448 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 687 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1796 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 157 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 209 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2004 | 184 | 0.060 |
Why?
| | Mice | 4 | 2014 | 14871 | 0.050 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 61 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2022 | 11 | 0.050 |
Why?
| | Mouth Mucosa | 1 | 2022 | 79 | 0.050 |
Why?
| | Mosaicism | 1 | 2022 | 60 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2019 | 274 | 0.050 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2002 | 10 | 0.050 |
Why?
| | Models, Anatomic | 1 | 2002 | 87 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2003 | 87 | 0.050 |
Why?
| | Plasma Cells | 1 | 2002 | 56 | 0.050 |
Why?
| | Myeloproliferative Disorders | 1 | 2002 | 26 | 0.050 |
Why?
| | Lymphoproliferative Disorders | 1 | 2002 | 46 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 338 | 0.050 |
Why?
| | Heparin | 1 | 2002 | 224 | 0.050 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 178 | 0.050 |
Why?
| | Alternative Splicing | 1 | 2002 | 187 | 0.050 |
Why?
| | Indazoles | 1 | 2021 | 58 | 0.050 |
Why?
| | Risk Factors | 3 | 2020 | 8632 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 79 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 115 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 83 | 0.040 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2020 | 31 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 446 | 0.040 |
Why?
| | Signal Transduction | 3 | 2019 | 4515 | 0.040 |
Why?
| | Risk Assessment | 1 | 2009 | 2968 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 498 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 847 | 0.040 |
Why?
| | Tumor Hypoxia | 1 | 2019 | 5 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 51 | 0.040 |
Why?
| | Coronary Occlusion | 1 | 2019 | 18 | 0.040 |
Why?
| | Age Factors | 2 | 2016 | 2894 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2019 | 9088 | 0.040 |
Why?
| | Interleukin-15 | 1 | 2019 | 74 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 278 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 187 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 149 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2019 | 99 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 221 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 45 | 0.040 |
Why?
| | Tumor Burden | 1 | 2019 | 259 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1121 | 0.040 |
Why?
| | Pyrimidines | 1 | 2021 | 376 | 0.040 |
Why?
| | Nucleoside Transport Proteins | 1 | 2017 | 4 | 0.040 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 92 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2019 | 413 | 0.040 |
Why?
| | Neurons | 1 | 2005 | 1280 | 0.040 |
Why?
| | Azathioprine | 1 | 2017 | 49 | 0.040 |
Why?
| | Sulfonamides | 1 | 2021 | 445 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 342 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2006 | 4411 | 0.040 |
Why?
| | Sex Distribution | 1 | 2018 | 337 | 0.040 |
Why?
| | Pleura | 1 | 2017 | 18 | 0.040 |
Why?
| | Risk | 1 | 2020 | 812 | 0.040 |
Why?
| | Prosthesis Failure | 1 | 2018 | 115 | 0.040 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 180 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 16 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 522 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2017 | 57 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 18 | 0.030 |
Why?
| | Prednisone | 1 | 2017 | 229 | 0.030 |
Why?
| | Neoplasms | 1 | 2010 | 2097 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 57 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 313 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 320 | 0.030 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2017 | 109 | 0.030 |
Why?
| | Methotrexate | 1 | 2017 | 226 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 285 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 249 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 430 | 0.030 |
Why?
| | Heart | 1 | 2020 | 612 | 0.030 |
Why?
| | Radiography | 1 | 2018 | 812 | 0.030 |
Why?
| | Disease Progression | 2 | 2019 | 2380 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 449 | 0.030 |
Why?
| | United States | 3 | 2018 | 12185 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 778 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 292 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 760 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 95 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 271 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 700 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 497 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 89 | 0.030 |
Why?
| | North America | 1 | 2015 | 256 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2015 | 166 | 0.030 |
Why?
| | Elastin | 1 | 2014 | 78 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1369 | 0.030 |
Why?
| | Stents | 1 | 2018 | 475 | 0.030 |
Why?
| | Cohort Studies | 2 | 2018 | 4895 | 0.030 |
Why?
| | Regeneration | 1 | 2015 | 160 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2019 | 823 | 0.030 |
Why?
| | Pancreatectomy | 1 | 2015 | 171 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 213 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 195 | 0.030 |
Why?
| | Retreatment | 1 | 2013 | 67 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 109 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1125 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 76 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 813 | 0.030 |
Why?
| | Gene Order | 1 | 2013 | 24 | 0.030 |
Why?
| | Albumins | 1 | 2013 | 89 | 0.030 |
Why?
| | Liver Failure, Acute | 1 | 2013 | 58 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2017 | 532 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1578 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 143 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2013 | 133 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2013 | 117 | 0.030 |
Why?
| | Gene Dosage | 1 | 2013 | 129 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 323 | 0.030 |
Why?
| | Collagen | 1 | 2014 | 415 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2710 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2016 | 966 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2251 | 0.020 |
Why?
| | Wilms Tumor | 1 | 2013 | 68 | 0.020 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.020 |
Why?
| | Phenyl Ethers | 1 | 2011 | 3 | 0.020 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 2011 | 15 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 487 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2013 | 206 | 0.020 |
Why?
| | S100 Proteins | 1 | 2011 | 38 | 0.020 |
Why?
| | Hemagglutinins | 1 | 2011 | 9 | 0.020 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 67 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2012 | 102 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 149 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 436 | 0.020 |
Why?
| | Isoantibodies | 1 | 2011 | 57 | 0.020 |
Why?
| | Radiosurgery | 1 | 2013 | 299 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2012 | 239 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1131 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1841 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 1950 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1373 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2010 | 48 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2003 | 2177 | 0.020 |
Why?
| | Shock, Septic | 1 | 2012 | 186 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1760 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 2012 | 212 | 0.020 |
Why?
| | HLA Antigens | 1 | 2011 | 225 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 4694 | 0.020 |
Why?
| | Arthralgia | 1 | 2010 | 46 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 869 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 951 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 1982 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 504 | 0.020 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2015 | 505 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2785 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 523 | 0.020 |
Why?
| | Endocrine System Diseases | 1 | 2007 | 30 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6220 | 0.020 |
Why?
| | Growth Disorders | 1 | 2007 | 77 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2007 | 99 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 122 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1841 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2007 | 187 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 638 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2320 | 0.010 |
Why?
| | Nervous System Diseases | 1 | 2007 | 256 | 0.010 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2002 | 16 | 0.010 |
Why?
| | Purpura | 1 | 2002 | 13 | 0.010 |
Why?
| | Karyotyping | 1 | 2002 | 102 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 72 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 163 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2002 | 157 | 0.010 |
Why?
| | Bone Marrow | 1 | 2002 | 243 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2002 | 177 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 993 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3053 | 0.010 |
Why?
| | RNA, Viral | 1 | 2002 | 565 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2002 | 1083 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2128 | 0.010 |
Why?
|
|
Galambos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|